Graham Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,378
| Closed | -$106K | – | 1471 |
|
|
2025
Q1 | $106K | Buy |
10,378
+3,917
| +61% | +$40K | ﹤0.01% | 1174 |
|
|
2024
Q4 | $90.1K | Buy |
6,461
+5,191
| +409% | +$72.4K | ﹤0.01% | 1139 |
|
|
2024
Q3 | $24.8K | Sell |
1,270
-553
| -30% | -$10.8K | ﹤0.01% | 1022 |
|
|
2024
Q2 | $33.9K | Buy |
+1,823
| New | +$33.9K | ﹤0.01% | 968 |
|
|
2023
Q3 | – | Sell |
-1,606
| Closed | -$13.9K | – | 1190 |
|
|
2023
Q2 | $13.9K | Sell |
1,606
-39,387
| -96% | -$340K | ﹤0.01% | 918 |
|
|
2023
Q1 | $432K | Buy |
40,993
+12,200
| +42% | +$129K | 0.01% | 769 |
|
|
2022
Q4 | $976K | Buy |
28,793
+7,169
| +33% | +$243K | 0.03% | 533 |
|
|
2022
Q3 | $1.04M | Buy |
21,624
+4,573
| +27% | +$219K | 0.04% | 460 |
|
|
2022
Q2 | $971K | Buy |
17,051
+9,596
| +129% | +$546K | 0.04% | 439 |
|
|
2022
Q1 | $602K | Buy |
+7,455
| New | +$602K | 0.02% | 482 |
|